Stock info BB Biotech | Filter  Basic-Info

Stock: BB Biotech (Swiss Midcap), ISIN: CH0038389992

Last Price 48.05 Max Price 50.20
Min Price 35.60 1 Year return -37.72
Sector Health Care Subsector Biotechnology
Annual report 2015

Loading...

Contact info:Country: SwitzerlandWebsite: www.bbbioec.com

Sector Review BB Biotech

Loading...
Year Turnover Total sector Market share
2019 728 141,925 0.51 %
2020 742 170,231 0.44 %
2021 -344 252,886 -0.14 %
2022 1 238,500 0.00 %
2023 0 0 0.00 %

Advice BB Biotech

Date Label Bank Label Stock Label Advice Label Price Label Diff Label
May 06, 2020 Baader Bank BB Biotech Buy 68.00 12.35 %
August 29, 2019 Independent Research BB Biotech Hold 63.00 5.40 %
January 24, 2019 Independent Research BB Biotech Hold 61.00 -8.93 %
April 22, 2017 Independent Research BB Biotech Hold 55.00 -19.73 %
August 09, 2016 Equinet-ag BB Biotech Buy 52.00 -14.62 %
February 09, 2016 ER Capital BB Biotech Buy
April 30, 2015 Equinet-ag BB Biotech Buy 288.00 82.08 %
April 20, 2015 Oddo BHF BB Biotech Buy 310.00 80.77 %
April 20, 2015 Independent Research BB Biotech Sell 255.00 79.76 %
February 23, 2015 Independent Research BB Biotech Sell 210.00 -16.90 %
October 20, 2014 Equinet-ag BB Biotech Buy 196.00 -33.16 %
October 17, 2014 Independent Research BB Biotech Hold 150.00 -71.67 %
September 02, 2014 Independent Research BB Biotech Hold 155.00 -81.77 %
July 21, 2014 Oddo BHF BB Biotech Buy 150.00 -114.83 %
July 18, 2014 Equinet-ag BB Biotech Buy 164.00 -94.21 %
June 27, 2014 Independent Research BB Biotech Buy 150.00 -91.33 %
April 23, 2014 Oddo BHF BB Biotech Buy 160.00 -86.88 %
April 22, 2014 Equinet-ag BB Biotech Buy 156.00 -89.58 %
April 17, 2014 Independent Research BB Biotech Buy 140.00 -105.71 %
February 25, 2014 Equinet-ag BB Biotech Hold 149.00
October 21, 2013 Equinet-ag BB Biotech Buy 121.00
June 10, 2013 Equinet-ag BB Biotech Buy 115.00
October 18, 2012 Independent Research BB Biotech Hold 86.00
July 26, 2012 Oddo BHF BB Biotech Buy 85.00
July 13, 2012 Independent Research BB Biotech Buy 80.00
May 08, 2012 Equinet-ag BB Biotech Buy 73.00
April 24, 2012 Oddo BHF BB Biotech Buy 70.00
April 19, 2012 Independent Research BB Biotech Buy 70.00
February 01, 2012 Independent Research BB Biotech Hold 62.00
December 22, 2011 Hamburger Sparkasse BB Biotech Hold
December 07, 2011 Independent Research BB Biotech Buy 59.00
December 05, 2011 Equinet-ag BB Biotech Buy 62.00
October 27, 2011 Oddo BHF BB Biotech Buy 54.00
September 06, 2011 Deutsche Bank BB Biotech Buy 62.50
July 27, 2011 Oddo BHF BB Biotech Buy 57.00
May 11, 2011 Hamburger Sparkasse BB Biotech Buy
May 02, 2011 Oddo BHF BB Biotech Buy 56.00
April 27, 2011 Independent Research BB Biotech Buy 61.00
March 25, 2011 Fuchsbriefe BB Biotech Buy 61.56
March 21, 2011 Equinet-ag BB Biotech Buy 66.00



News BB Biotech

Analysts expect over 2021 decreasing revenue BB Biotech, huge dividend

Tomorrow the Swiss BB Biotech will publish its past quarters figures. For this year the company from Schaffhausen could earn a total revenue around 0 million CHF. This is according to the average of the analysts' estimates. This is hugely lower than 2020's revenue...

Analysts expect over 2019 rising revenue BB Biotech, huge dividend

Tomorrow the Swiss BB Biotech will report its past quarters results. Over the current book year the total revenue will be 151,23 million CHF (consensus estimates). This is rather significant more than 2018's revenue of 5,78 million CHF. Historical revenues and...

Extreme high dividend stock BB Biotech

Huge dividend BB Biotech Investors in BB Biotech can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Per share the analysts expect a dividend of 3,37 CHF per...

Extreme high dividend stock BB Biotech

Huge dividend BB Biotech Investors in BB Biotech can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Analysts expect a dividend of 3,18 CHF per share. BB Biotech...

Analysts expect over 2018 decreasing revenue BB Biotech, high dividend yield

Tomorrow BB Biotech will publish its past quarter's results. For this year BB Biotech 's revenue will be around 0 million CHF. This is according to the average of the analysts' estimates. This is rather significant lower than 2016's revenue of 730,05 million...

Annual reports BB Biotech

2017 2018 2019 2020 2021

Profile BB Biotech

BB Biotech

(CH0038389992)/ BBZ

The company mostly operates in the biotech sector. Over the past 10 years the global biotech companies gained around 59 percent. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.

The past year was a profitable year for BB Biotech investors

Over the last 12 months (from December 2015 till December 2016), that were loss-making period for the investors in BB Biotech, the stock lost around 5 percent. Over the past 5 years BB Biotech' stock rose at around 361 percent in value. BB Biotech's revenues between 2011 and 2015 were very volatile and moved between 391,99 million CHFF and 697,95 million CHFF. BB Biotech's net results between 2011 and 2015 were very fluctuating and moved between -65,14 million CHFF and 652,82 million CHFF.

The Swiss company paid out dividends in the past 5 years. On average BB Biotech's dividend yield over the past 5 years was around 7,52 percent annually.

BB Biotech financed with relatively a lot of debt

Last year the balance sheet of the Swiss company was worth 4,14 billion CHFF. Of the total balance sheet 165,51 million CHFF (3,99 percent) was financed by debt. At the end of 2015 the biotech company's stock was traded with a price/earnings-ratio 4. So the stock' value was 4 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the Swiss stock can be seen as a value stock.

The biotech company's market capitalization (the number of shares outstanding times the market value) equaled around 3,19 billion CHFF. At the end of 2015 the Swiss company had around 55,85 million stocks listed.

All of BB Biotech's annual reports are stored here. More information about BB Biotech can be found it's website. .


Results BB Biotech

Results
2015
2016
2017
2018
2019
2020
Revenue
698
10
730
6
728
742
Costs
45
812
43
477
51
51
Profit
653
-802
688
-471
677
691
Margin of profit
93.53
-8442.84
94.17
-8154.67
93.03
93.18
ROI
16.41
-26.71
19.43
-16.34
19.97
17.78

Balance BB Biotech

Balance
2015
2016
2017
2018
2019
2020
Equity
3,978
3,003
3,539
2,885
3,393
3,888
Debt
166
223
99
202
162
76
Total assets
4,144
3,226
3,638
3,087
3,555
3,963
Solvency
96.01
93.08
97.28
93.45
95.45
98.09
Cash
3,790
2,816
3,238
2,386
2,854
3,261
Cashflow
53
115
263
108
215
262
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
0.32
0.52
2.66
0.53
1.33
3.47

Details BB Biotech

Details
2016
2017
2018
2019
2020
Price
58.45
55.10
64.55
58.40
66.25
Eps
-14.51
12.42
-8.51
12.23
12.48
Price/earnings-ratio
-4.03
4.44
-7.59
4.78
3.85
Dividend
2.75
3.30
3.05
3.40
3.60
Dividend %
4.70 %
5.99 %
4.73 %
5.82 %
7.49 %
Payout %
-0.19
0.27
-0.36
0.28
0.29
Book value
54.22
63.88
52.07
61.24
70.32
Market to book
0.93
1.16
0.81
1.05
1.46
Cashflow per stock
2.08
4.76
1.95
3.88
4.75
Stocks
55
55
55
55
55
Market Cap
3.237.21
3.052.54
3.576.07
3.235.36
2.656.46

Dividend BB Biotech


Price info BB Biotech

Date
Price
22 Mar 2024
48.05
18 Mar 2024
47.65
15 Mar 2024
47.35
12 Mar 2024
48.95
11 Mar 2024
48.35
09 Mar 2024
48.35
07 Mar 2024
46.65
01 Mar 2024
45.80
29 Feb 2024
46.60
27 Feb 2024
48.10
22 Feb 2024
48.25
21 Feb 2024
48.75
20 Feb 2024
49.25
15 Feb 2024
49.25
14 Feb 2024
48.05
13 Feb 2024
48.35
09 Feb 2024
47.80
08 Feb 2024
47.80
07 Feb 2024
46.05
06 Feb 2024
45.20
05 Feb 2024
44.20
01 Feb 2024
44.65
31 Jan 2024
44.65
30 Jan 2024
44.15
27 Jan 2024
44.10
25 Jan 2024
44.00
24 Jan 2024
44.00
23 Jan 2024
43.40
16 Jan 2024
44.35
11 Jan 2024
44.55